Early Access — free while we kick the tires
EdgarHawk

QUAY STEVEN C

President & CEO

Director Officer
1 filing analyzed · 1 company · Latest 2025-05-22

Companies

Company Buys Sells Direction
ATOSSA THERAPEUTICS, INC. ATOS 1 0 Net buying

Activity

May 2025
high
Buy
11,239 shares
$9,887
Significance 6/10

ATOS CEO QUAY purchases 11,239 shares at $0.88, increasing holdings 422.7%; company burns cash amid 99.7% revenue decline

CEO Steven C. Quay acquired 11,239 shares at $0.88, bringing his total position to 13,898 shares and raising his ownership by 422.7% from 2,659 shares. This is a substantial voluntary accumulation at a price far below the current $13.05 level and significantly below the 52-week high of $24.45. However, the company's recent financial state demands scrutiny: latest quarterly revenue is $0.00, annual revenue growth is -99.7%, and net income was -$6,718,000 in the most recent full fiscal year. The 30-day price surge of +31.1% and 90-day gain of +9.4% suggest recent upward momentum, but fundamental profitability and revenue remain absent. This purchase warrants deeper examination into the company's cash runway, path to revenue, and whether the CEO's acquisition reflects asymmetric information or is a routine equity stake alignment gesture.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access